Rhumbline Advisers reduced its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.0% during t...
Harbor Capital Advisors Inc. bought a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in ...
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have received an average rating of “Buy” fr...
Here is how Astellas Pharma Inc. (ALPMY) and AtriCure (ATRC) have performed compared to their sector...